Stay updated on ABP798 vs Rituximab in NHL: Clinical Trial
Sign up to get notified when there's something new on the ABP798 vs Rituximab in NHL: Clinical Trial page.

Latest updates to the ABP798 vs Rituximab in NHL: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe Locations section now includes added sites across multiple countries and regions and removes several existing sites. This updates the official list of participating study sites for the trial.SummaryDifference3%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.3.1 was removed, indicating a minor site version update with no changes to the study information; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedPublication attribution text was updated to indicate PubMed-derived publications are automatically filled and may not pertain to the study, and the revision tag was updated to v3.3.1.SummaryDifference0.1%

- Check55 days agoChange DetectedRemoved the government funding operating status notice from the page header. The notice previously informed users about potential delays in updates and responses due to appropriations.SummaryDifference0.2%

- Check69 days agoChange DetectedNo significant content changes detected on the Study Details page; core information such as the study title, interventions, eligibility criteria, outcomes, and locations remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check98 days agoChange DetectedUpdate to a newer revision identifier (v3.2.0) replaces the older v3.0.2.SummaryDifference0.1%

Stay in the know with updates to ABP798 vs Rituximab in NHL: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABP798 vs Rituximab in NHL: Clinical Trial page.